THRD

Third Harmonic Bio Inc.

NASDAQ: THRD · HEALTHCARE · BIOTECHNOLOGY

$5.38

+0.00% today

Updated 2026-06-05

Market cap

$242.79M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.24

Dividend yield

—

52W range

$5 – $6

Volume

—

Market cap

$242.79M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.24

Dividend yield

—

52W range

$5 – $6

Volume

—

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

18.0

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$3.00

-44.24%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Altman Z 17.98 — safe zone

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-13.48M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-29.61M	$-37.71M	$-30.82M	$45.47M	$-15.83M
EPS	—	—	—	—	$-1.24
Free cash flow	$-15.78M	$-34.95M	$-20.59M	$-34.51M	$-13.48M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
THRD	$242.79M	32	4.3	3.0	5.0	8.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Third Harmonic Bio Inc. trades at $5.38. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 17.98, it sits in the safe zone.

Frequently asked questions

What is Third Harmonic Bio Inc.'s stock price?

Third Harmonic Bio Inc. (THRD) trades at $5.38.

Is Third Harmonic Bio Inc. overvalued?

Third Harmonic Bio Inc. carries a Smart Value Score of 32/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Third Harmonic Bio Inc. (THRD)?

The 12-month analyst consensus target is $3.00, about 44.2% below the current $5.38. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Third Harmonic Bio Inc.'s Altman Z-Score is 17.98, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-19.60%

Beta2.13

50D MA$5.40

200D MA$6.51

Shares out0.05B

Float0.02B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

THRD vs LLY →THRD vs JNJ →THRD vs ABBV →Stock screener →